Skip to main content
AAN.com
Brief Communications
June 13, 2000

Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism

June 13, 2000 issue
54 (11) 2182-2184

Abstract

Article abstract The authors report a patient with postischemic parkinsonism who responded neither to levodopa nor to bilateral subthalamic nucleus (STN) stimulation. MRI revealed bilateral lesions of the substantia nigra, the striatum, the external pallidum, and part of the internal pallidum. PET showed reduced striatal dopa-decarboxylase activity, D2 receptor binding, and glucose metabolism. Perioperative microrecording showed low-frequency activity of STN cells. This case suggests that parkinsonian patients who do not have a good response to levodopa or in whom a postsynaptic dopaminergic lesion can be shown may not be good candidates for STN surgery.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Krack P, Hamel W, Mehdorn HM, Deuschl G. Surgical treatment of Parkinson’s disease. Curr Opin Neurol 1999;12:417–425.
2.
Fazzini E, Dogali M, Beric A, et al. The effects of unilateral ventral posterior medial pallidotomy in patients with Parkinson’s disease and Parkinson’s plus syndromes. In: Koller WC, Paulson G, eds. Therapy of Parkinson’s disease. 2nd ed. New York:Marcel Dekker, 1994:353–379.
3.
Lang AE, Lozano A, Duff J, et al. Medial pallidotomy in late-stage Parkinson’s disease and striatonigral degeneration. In: Obeso JA, DeLong MR, Ohye C, Marsden CD, eds. The basal ganglia and new surgical approaches for Parkinson’s disease. Philadelphia:Lippincott-Raven, 1997:199–210.
4.
Goto S, Kunitoku N, Soyama N, et al. Posteroventral pallidotomy in a patient with parkinsonism caused by hypoxic encephalopathy. Neurology 1997;49:707–710.
5.
Krauss JK, Jankovic J, Lai EC, Rettig GM, Grossman RG. Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism. Arch Neurol 1997;54:1026–1029.
6.
Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 1998;339:1105–1111.
7.
Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436–1438.
8.
Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson’s disease. Ann Neurol 1998;44:622–628.
9.
Krack P, Limousin P, Pollak P, Benazzouz A, Koudsie A, Benabid AL. The preoperative response to an acute L-dopa-test predicts the outcome of subthalamic nucleus stimulation in Parkinson’s disease. Mov Disord 1998;13 (suppl 2):296. Abstract.
10.
Pinter MM, Alesch F, Murg M, Helscher RJ, Binder H. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus. J Neurol 1999;246:907–913.

Information & Authors

Information

Published In

Neurology®
Volume 54Number 11June 13, 2000
Pages: 2182-2184
PubMed: 10851392

Publication History

Received: August 6, 1999
Accepted: February 10, 2000
Published online: June 13, 2000
Published in print: June 13, 2000

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

P. Krack, MD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.
P. Limousin Dowsey, MD, PhD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.
A.L. Benabid, MD, PhD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.
N. Acarin, MD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.
A. Benazzouz, PhD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.
G. Künig, MD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.
K.L. Leenders, MD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.
J.A. Obeso, MD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.
P. Pollak, MD
From the Department of Clinical and Biological Neurosciences (Drs. KrackLimousin Dowsey, Benabid, Benazzouz, and Pollak), Joseph Fourier University, Grenoble, France; the Neurology Department (Dr. Krack), Christian Albrechts Universität Kiel, Germany; MRC Human Movement and Balance Unit (Dr. Limousin Dowsey), Queen Square, London, England; Paul Scherrer Institut Villigen (Drs. Künig and Leenders), Switzerland; Neurology Department (Dr. Leenders), University of Groningen, the Netherlands; Neurology Service (Dr. Acarin), Hospital Valle de Hebron, Barcelona; and the Division of Neuroscience (Dr. Obeso), Clinica Universitaria and Medical School, University of Navarra, Pamplona, Spain.

Notes

Address correspondence and reprint requests to Dr. Paul Krack, Neurology Department, University of Kiel, Niemannsweg 147, 24105 Kiel, Germany; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Lower-Body Parkinsonism, Case-based Approach to Common Neurological Disorders, (227-236), (2024).https://doi.org/10.1007/978-981-99-8676-7_26
    Crossref
  2. Quality of life predicts outcome of deep brain stimulation in early Parkinson disease, Neurology, 92, 10, (e1109-e1120), (2019)./doi/10.1212/WNL.0000000000007037
    Abstract
  3. Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: From history to the interaction with the monoaminergic systems, Progress in Neurobiology, 151, (139-156), (2017).https://doi.org/10.1016/j.pneurobio.2016.07.003
    Crossref
  4. Vascular Parkinsonism, Movement Disorders Curricula, (233-247), (2017).https://doi.org/10.1007/978-3-7091-1628-9_22
    Crossref
  5. Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson's disease patients, British Journal of Neurosurgery, 29, 3, (329-333), (2015).https://doi.org/10.3109/02688697.2014.997665
    Crossref
  6. Vascular parkinsonism—characteristics, pathogenesis and treatment, Nature Reviews Neurology, 11, 6, (319-326), (2015).https://doi.org/10.1038/nrneurol.2015.61
    Crossref
  7. Therapeutic extradural cortical stimulation for movement disorders: A review, Neurological Research, 25, 2, (118-122), (2013).https://doi.org/10.1179/016164103101201238
    Crossref
  8. Motor improvement with bilateral subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive secondary parkinsonism, Parkinsonism & Related Disorders, 18, 1, (79-81), (2012).https://doi.org/10.1016/j.parkreldis.2011.08.014
    Crossref
  9. Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease, Biocybernetics and Biomedical Engineering, 31, 3, (47-55), (2011).https://doi.org/10.1016/S0208-5216(11)70018-3
    Crossref
  10. Deep brain stimulation of the subthalamic nucleus in Parkinson's Disease 1993 – 2003: where are we 10 years on?, British Journal of Neurosurgery, 18, 1, (19-34), (2009).https://doi.org/10.1080/02688690410001660427
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share